A 63-year-old woman, previously treated for endometrial cancer using
chemoradiotherapy, came in for additional diagnosis. Imaging studies showed uterine
tumors that had extended to the parametrium. The patient had a radical hysterectomy
along with bilateral salpingo-oophorectomy. The histopathological examination verified
G2 endometrioid adenocarcinoma (FIGO stage II) and a borderline ovarian tumor.
Because of a p53 mutation, the patient received adjuvant chemotherapy and
brachytherapy. Follow-up MRI revealed suspicious lesions in the vaginal and vulvar
areas, including a mass in the left labium majus. The doctor initiated hormonal therapy.
Given the tumor size, surgical excision of the vulvar lesion and vaginal nodules was
performed, with histopathology confirming recurrence of endometrioid carcinoma. Due
to further disease progression, the medical team introduced immunotherapy. This case is
an example of a rare location of endometrial cancer recurrence on the vulva and in the
vagina. It highlights the need for an individualized approach to each patient, analysis of
possible treatment strategies, and selection of the appropriate therapy, particularly in
patients with high-risk molecular profiles.
Keywords: endometrial cancer, vulvar metastasis, treatment
